Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
# | Code | QID |
Subspecialty
|
Topic
|
Complexity
|
Importance
|
|
---|---|---|---|---|---|---|---|
1 | M1.PY.17.4698 | 108207 | Personality Disorders |
M 3
|
A
|
||
2 | M1.OMB.20.4673 | 214219 | Chronic Kidney Disease (CKD) |
M 2
|
A
|
||
3 | M1.BC.17.4695 | 107982 | Fat Soluble Vitamins |
M 1
|
A
|
||
4 | M1.OMB.1 | 214770 | Ethical Principles |
M 1
|
A
|
||
5 | M1.OMB.4874 | 214529 | Ethical Principles |
M 1
|
A
|
||
6 | M1.OMB.1 | 214355 | Ethical Principles |
M 3
|
A
|
||
7 | M1.OMB.4875 | 214775 | Ethical Principles |
M 1
|
A
|
||
8 | M1.OMB.20.1 | 213740 | Ethical Principles |
M 3
|
A
|
||
9 | M1.OMB.1 | 215241 | Ethical Principles |
M 3
|
A
|
||
10 | M1.OMB.4873 | 215002 | Ethical Principles |
M 1
|
A
|
||
11 | M1.OMB.1 | 214605 | Ethical Principles |
M 1
|
A
|
||
12 | M1.OMB.4771 | 214774 | Legal Principles |
M 1
|
A
|
||
13 | M1.OMB.20.4770 | 214203 | Legal Principles |
M 1
|
A
|
||
14 | M1.OMB.1 | 214645 | Legal Principles |
M 1
|
A
|
||
15 | M1.OMB.4735 | 215330 | Testing and Screening |
M 1
|
A
|
||
16 | M1.OMB.4733 | 215223 | Testing and Screening |
M 1
|
A
|
||
17 | M1.OMB.4732 | 214850 | Testing and Screening |
M 1
|
A
|
||
18 | M1.OMB.20.4730 | 213799 | Testing and Screening |
A
|
|||
19 | M1.OMB.4736 | 215398 | Testing and Screening |
M 1
|
A
|
||
20 | M1.OMB.4731 | 214561 | Testing and Screening |
M 1
|
A
|
||
21 | M1.OMB.4734 | 215292 | Testing and Screening |
M 1
|
A
|
||
22 | M1.OMB.1 | 214602 | Testing and Screening |
M 1
|
A
|
||
23 | M1.OMB.20.1 | 214196 | Acute Kidney Injury |
M 2
|
A
|
||
24 | M1.CV.15.75 | 106831 | Cardiac Cycle |
M 1
|
A
|
||
25 | M1.OMB.1 | 214959 | Lipid Lowering Drugs |
M 3
|
A
|
||
26 | M1.OMB.1 | 214372 | Lipid Lowering Drugs |
M 3
|
A
|
||
27 | M1.OMB.1 | 215206 | Lipid Lowering Drugs |
M 3
|
A
|
||
28 | M1.OMB.4887 | 215247 | Lipid Lowering Drugs |
M 1
|
A
|
||
29 | M1.OMB.1 | 214611 | Lipid Lowering Drugs |
M 3
|
A
|
||
30 | M1.OMB.4886 | 214347 | Lipid Lowering Drugs |
M 3
|
A
|
||
31 | M1.OMB.4885 | 214681 | Observational Studies |
M 1
|
A
|
||
32 | M1.OMB.1 | 214777 | Observational Studies |
M 1
|
A
|
||
33 | M1.OMB.4886 | 214746 | Observational Studies |
M 1
|
A
|
||
34 | M1.OMB.4887 | 214806 | Observational Studies |
M 1
|
A
|
||
35 | M1.OMB.1 | 214713 | Observational Studies |
M 1
|
A
|
||
36 | M1.OMB.4876 | 215179 | Congestive Heart Failure |
M 2
|
A
|
||
37 | M1.OMB.1 | 215108 | Congestive Heart Failure |
M 3
|
A
|
||
38 | M1.OMB.20.1 | 213781 | Congestive Heart Failure |
M 3
|
A
|
||
39 | M1.OMB.1 | 215219 | Congestive Heart Failure |
M 2
|
A
|
||
40 | M1.OMB.20.4875 | 214229 | Congestive Heart Failure |
M 2
|
A
|
||
41 | M1.OMB.1 | 214427 | Modes of Inheritance |
M 2
|
A
|
||
42 | M1.OMB.1 | 214915 | Modes of Inheritance |
M 1
|
A
|
||
43 | M1.OMB.20.4875 | 213879 | Modes of Inheritance |
M 1
|
A
|
||
44 | M1.OMB.4876 | 214474 | Modes of Inheritance |
M 1
|
A
|
||
45 | M1.OMB.20.1 | 213780 | Lysosome |
M 2
|
A
|
||
46 | M1.OMB.20.1 | 214271 | Lysosome |
M 2
|
A
|
||
47 | M1.OMB.1 | 214601 | Lysosome |
M 2
|
A
|
||
48 | M1.OMB.4801 | 215387 | Lysosome |
M 2
|
A
|
||
49 | M1.OMB.1 | 214613 | Mycobacterium Tuberculosis |
M 4
|
A
|
||
50 | M1.OMB.4799 | 214711 | Mycobacterium Tuberculosis |
M 1
|
A
|
||
51 | M1.OMB.1 | 214914 | Myocardial Infarction |
M 1
|
A
|
||
52 | M1.OMB.4800 | 214991 | Mycobacterium Tuberculosis |
M 1
|
A
|
||
53 | M1.OMB.1 | 214365 | Myocardial Infarction |
M 1
|
A
|
||
54 | M1.OMB.1 | 215221 | Myocardial Infarction |
M 2
|
A
|
||
55 | M1.OMB.4875 | 214454 | Myocardial Infarction |
M 2
|
A
|
||
56 | M1.OMB.4889 | 215031 | Statistical Distribution |
M 1
|
A
|
||
57 | M1.ST.12.4887 | 214373 | Statistical Distribution |
M 1
|
A
|
||
58 | M1.OMB.1 | 214633 | Statistical Distribution |
M 1
|
A
|
||
59 | M1.OMB.4888 | 214925 | Statistical Distribution |
M 1
|
A
|
||
60 | M1.OMB.112 | 215175 | Cystic Fibrosis |
M 1
|
A
|
||
61 | M1.OMB.1 | 215228 | Cystic Fibrosis |
M 1
|
A
|
||
62 | M1.OMB.113 | 215401 | Cystic Fibrosis |
M 2
|
A
|
||
63 | M1.OMB.111 | 215065 | Cystic Fibrosis |
M 1
|
A
|
||
64 | M1.OMB.4769 | 215036 | Baroreceptors and Chemoreceptors |
M 2
|
A
|
||
65 | M1.OMB.1 | 215174 | Baroreceptors and Chemoreceptors |
M 1
|
A
|
||
66 | M1.OMB.20.1 | 214276 | Cranial Nerves |
M 2
|
A
|
||
67 | M1.OMB.4875 | 215388 | Cranial Nerves |
M 2
|
A
|
||
68 | M1.OMB.20.1 | 214193 | Statistical Measures |
M 1
|
A
|
||
69 | M1.OMB.20.4767 | 214302 | Statistical Measures |
M 1
|
A
|
||
70 | M1.OMB.4768 | 214930 | Baroreceptors and Chemoreceptors |
M 3
|
A
|
||
71 | M1.OMB.4770 | 215242 | Baroreceptors and Chemoreceptors |
M 1
|
A
|
||
72 | M1.OMB.4873 | 215014 | Cranial Nerves |
M 4
|
A
|
||
73 | M1.OMB.4768 | 215112 | Statistical Measures |
M 1
|
A
|
||
74 | M1.OMB.20.4767 | 213839 | Baroreceptors and Chemoreceptors |
M 1
|
A
|
||
75 | M1.OMB.20.1 | 214199 | Baroreceptors and Chemoreceptors |
M 1
|
A
|
||
76 | M1.OMB.4874 | 215091 | Cranial Nerves |
M 4
|
A
|
||
77 | M1.OMB.4803 | 215200 | Diabetes Drugs |
M 3
|
A
|
||
78 | M1.OMB.1 | 214773 | Diabetes Drugs |
M 3
|
A
|
||
79 | M1.OMB.4802 | 214981 | Diabetes Drugs |
M 1
|
A
|
||
80 | M1.OMB.20.138 | 213869 | Emphysema |
M 2
|
A
|
||
81 | M1.OMB.139 | 215012 | Emphysema |
M 2
|
A
|
||
82 | M1.OMB.4875 | 215061 | Water Soluble Vitamins |
M 1
|
A
|
||
83 | M1.OMB.1 | 215345 | Water Soluble Vitamins |
M 2
|
A
|
||
84 | M1.OMB.1 | 214598 | Emphysema |
M 1
|
A
|
||
85 | M1.OMB.1 | 215130 | Water Soluble Vitamins |
M 1
|
A
|
||
86 | M1.OMB.4868 | 215222 | Amino Acid Catabolism |
M 1
|
A
|
||
87 | M1.OMB.20.1 | 213854 | Cardiomyopathies |
M 2
|
A
|
||
88 | M1.OMB.1 | 214889 | Cardiomyopathies |
M 2
|
A
|
||
89 | M1.OMB.4868 | 214483 | Bias |
M 1
|
A
|
||
90 | M1.OMB.1 | 214982 | Amino Acid Catabolism |
M 2
|
A
|
||
91 | M1.OMB.1 | 215073 | Cardiomyopathies |
M 2
|
A
|
||
92 | M1.OMB.20.1 | 213887 | Amino Acid Catabolism |
M 1
|
A
|
||
93 | M1.OMB.1 | 215379 | Sickle Cell Anemia |
M 1
|
A
|
||
94 | M1.OMB.4803 | 214950 | Other Eating Disorders |
M 2
|
A
|
||
95 | M1.OMB.4802 | 214797 | Other Eating Disorders |
M 2
|
A
|
||
96 | M1.OMB.1 | 214517 | Asthma |
M 2
|
A
|
||
97 | M1.OMB.4698 | 214215 | Asthma |
M 3
|
A
|
||
98 | M1.OMB.20.4802 | 214288 | Germ Layer Derivatives |
M 2
|
A
|
||
99 | M1.OMB.20.4801 | 213892 | Other Eating Disorders |
M 4
|
A
|
||
100 | M1.OMB.4698 | 214697 | Sickle Cell Anemia |
M 1
|
A
|
||
101 | M1.OMB.1 | 214640 | Germ Layer Derivatives |
M 1
|
A
|
||
102 | M1.OMB.20.1 | 214275 | Valvular Disease |
M 2
|
A
|
||
103 | M1.OMB.1 | 214362 | Poisons and Treatments |
M 2
|
A
|
||
104 | M1.OMB.4755 | 214939 | Valvular Disease |
M 2
|
A
|
||
105 | M1.OMB.1 | 213853 | Ischemic Stroke |
M 2
|
A
|
||
106 | M1.OMB.4819 | 215050 | Ischemic Stroke |
M 3
|
A
|
||
107 | M1.OMB.1 | 215051 | Ego Defenses |
M 1
|
A
|
||
108 | M1.OMB.1 | 215339 | Nephritic Syndrome |
M 1
|
A
|
||
109 | M1.OMB.143 | 215003 | Chronic Bronchitis |
M 1
|
A
|
||
110 | M1.OMB.142 | 214524 | Chronic Bronchitis |
M 2
|
A
|
||
111 | M1.OMB.4800 | 214810 | Opportunistic Mycoses |
M 2
|
A
|
||
112 | M1.OMB.4818 | 214460 | Diabetes Mellitus |
M 2
|
A
|
||
113 | M1.OMB.1 | 214441 | Lung Cancer |
M 2
|
A
|
||
114 | M1.OMB.1 | 215173 | Drug Reactions and Side Effects |
M 4
|
A
|
||
115 | M1.OMB.4874 | 214926 | Drug Reactions and Side Effects |
M 3
|
A
|
||
116 | M1.OMB.20.1 | 213779 | Opiates |
M 3
|
A
|
||
117 | M1.OMB.20.1 | 213768 | Graves Disease |
M 2
|
A
|
||
118 | M1.OMB.4759 | 214653 | Urinary Tract Infection |
M 3
|
A
|
||
119 | M1.OMB.4800 | 214551 | Sarcoidosis |
M 1
|
A
|
||
120 | M1.OMB.20.1 | 214278 | Primary Brain Tumors |
M 2
|
A
|
||
121 | M1.OMB.20.4874 | 213726 | Primary Brain Tumors |
M 2
|
A
|
||
122 | M1.OMB.4870 | 215293 | Graves Disease |
M 3
|
A
|
||
123 | M1.OMB.4873 | 214330 | Drug Reactions and Side Effects |
M 2
|
A
|
||
124 | M1.OMB.20.4758 | 214220 | Urinary Tract Infection |
M 3
|
A
|
||
125 | M1.OMB.1 | 214323 | Opiates |
M 2
|
A
|
||
126 | M1.OMB.1 | 214610 | Chromosomal Diseases |
M 2
|
A
|
||
127 | M1.OMB.20.1 | 213883 | Opiates |
M 1
|
A
|
||
128 | M1.OMB.1 | 214735 | GI Embryology |
M 2
|
A
|
||
129 | M1.OMB.4770 | 214721 | Eye Movement |
M 2
|
A
|
||
130 | M1.OMB.4771 | 214936 | Eye Movement |
M 2
|
A
|
||
131 | M1.OMB.1 | 215259 | GI Embryology |
M 1
|
A
|
||
132 | M1.OMB.20.1 | 213882 | Atrioventricular (AV) Heart Block |
M 2
|
A
|
||
133 | M1.OMB.4755 | 214612 | Atrioventricular (AV) Heart Block |
M 2
|
A
|
||
134 | M1.OMB.4772 | 215060 | Eye Movement |
M 2
|
A
|
||
135 | M1.OMB.4727 | 215324 | Osteoporosis |
M 4
|
A
|
||
136 | M1.OMB.1 | 215342 | Fat Soluble Vitamins |
M 3
|
A
|
||
137 | M1.OMB.20.4868 | 213891 | Bruton Agammaglobulinemia |
M 2
|
A
|
||
138 | M1.OMB.1 | 214747 | Nephrolithiasis |
M 2
|
A
|
||
139 | M1.OMB.20.4886 | 214299 | Pneumoconioses |
M 2
|
A
|
||
140 | M1.OMB.4885 | 213793 | Pneumoconioses |
M 2
|
A
|
||
141 | M1.OMB.1 | 215165 | Antianginal Therapy |
M 3
|
A
|
||
142 | M1.OMB.4887 | 215338 | Pneumoconioses |
M 2
|
A
|
||
143 | M1.OMB.20.4870 | 213798 | Nephrolithiasis |
M 2
|
A
|
||
144 | M1.OMB.20.1 | 214273 | Fat Soluble Vitamins |
M 2
|
A
|
||
145 | M1.OMB.4725 | 214480 | Osteoporosis |
M 2
|
A
|
||
146 | M1.OMB.1 | 215249 | Bruton Agammaglobulinemia |
M 2
|
A
|
||
147 | M1.OMB.20.4754 | 214200 | Antianginal Therapy |
M 3
|
A
|
||
148 | M1.OMB.4726 | 214893 | Osteoporosis |
M 2
|
A
|
||
149 | M1.OMB.6002 | 214990 | Sympathomimetics |
M 2
|
A
|
||
150 | M1.OMB.4722 | 215000 | Hepatitis B Virus |
M 2
|
A
|